HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 65 - 70)

Switching All Patients from Racemic to Levomethadone as a Challenge to Public Health

Deruvo G., Elia C., Mercadante M., Mongiello F., Guareschi M., and Maremmani I.

Summary: The ‘real life' switch from racemic methadone to levomethadone in all patients receiving treatment at the Addiction Unit in Bitonto-Palo del Colle (province of Bari) proved to be a feasible option, both effective and well tolerated. Methadone and levomethadone can be safely switched in either direction to replace each other, applying a dose ratio between the two of approximately 2:1. In our experience, in fact, most of the patients needed progressive increases in their daily dose of levomethadone, in some cases using stepwise increases of over 30%. The need for constant updating in addiction medicine and for the implementation of this knowledge in clinical practice are further challenges in the field of public health. Public policies should aim to achieve clearly defined basic objectives that seek to change the social situation with the objective of solving a problem or improving a situation. These objectives may be arranged in the order of their importance, for example by distinguishing primary from secondary aims, or staggering separate interventions over time. In our opinion, the needs addressed by public policy are not only guaranteeing public health by avoiding the marginalization of dependent people and reducing the social burden arising from the problem of dependence. It is up to policy makers to go further by providing resources to improve the state of health of Substance Use Disorder patients. On this view, enacting any drug improvement promptly, in clinical practice and for all patients, is surely not a secondary or optional task of public health.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page